Sumitomo Mitsui Trust Group, Inc.
Position in LLY — ELI LILLY & Co
CIK 1475365
CHIYODA-KU, TOKYO, M0
Position in LLY
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$2,273,837,603
+$640,595,576 QoQ
Shares Held
1,895,765
+6.8% QoQ
Ownership
0.201%
of shares outstanding
% of Portfolio
1.34%
of 13F equity value
Holder Rank
#47
of 4,632 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Sumitomo Mitsui Trust Group, Inc. holds $7,122,175,515 across 9 Drug Manufacturers - General names. LLY ranks #1 (31.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
1,895,765 | $2,273,837,603 | |
| 2 | JNJ |
Johnson & Johnson
|
5,660,854 | $1,437,687,090 | |
| 3 | ABBV |
AbbVie Inc.
|
3,945,546 | $992,857,195 | |
| 4 | MRK |
Merck & Co., Inc.
|
6,169,107 | $792,730,249 | |
| 5 | AMGN |
Amgen Inc
|
1,520,877 | $550,739,979 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
2,962,648 | $374,300,948 | |
| 7 | PFE |
Pfizer Inc
|
13,775,929 | $331,724,370 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
5,092,121 | $293,408,012 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,273,837,603 | 1,895,765 | Shares | Defined | 2026-07-30 | |
| 2026-03-31 | $1,633,242,027 | 1,775,707 | Shares | Defined | 2026-04-30 | |
| 2025-12-31 | $1,994,748,123 | 1,856,132 | Shares | Defined | 2026-01-23 | |
| 2025-09-30 | $1,494,741,416 | 1,959,032 | Shares | Defined | 2025-10-27 | |
| 2025-06-30 | $1,506,910,222 | 1,933,101 | Shares | Defined | 2025-07-31 | |
| 2025-03-31 | $1,613,373,063 | 1,953,449 | Shares | Defined | 2025-04-25 | |
| 2024-12-31 | $1,495,464,360 | 1,937,130 | Shares | Defined | 2025-01-28 | |
| 2024-09-30 | $1,731,168,399 | 1,954,047 | Shares | Defined | 2024-11-05 | |
| 2024-06-30 | $1,758,250,676 | 1,942,003 | Shares | Defined | 2024-07-19 | |
| 2024-03-31 | $1,621,887,118 | 2,084,795 | Shares | Defined | 2024-04-19 | |
| 2023-12-31 | $1,226,000,841 | 2,103,206 | Shares | Defined | 2024-01-30 | |
| 2023-09-30 | $1,153,315,867 | 2,147,182 | Shares | Defined | 2023-10-30 | |
| 2023-06-30 | $1,009,173,675 | 2,151,848 | Shares | Defined | 2023-07-31 | |
| 2023-03-31 | $831,972,726 | 2,422,610 | Shares | Defined | 2023-04-27 | |
| 2022-12-31 | $894,448,801 | 2,444,918 | Shares | Defined | 2023-01-30 | |
| 2022-09-30 | $800,035,480 | 2,474,209 | Shares | Defined | 2022-10-21 | |
| 2022-06-30 | $806,124,294 | 2,486,273 | Shares | Defined | 2022-07-26 | |
| 2022-03-31 | $695,333,565 | 2,428,095 | Shares | Defined | 2022-04-27 | |
| 2021-12-31 | $671,681,135 | 2,431,689 | Shares | Defined | 2022-02-02 | |
| 2021-09-30 | $586,422,921 | 2,538,078 | Shares | Defined | 2021-10-25 | |
| 2021-06-30 | $619,461,626 | 2,698,944 | Shares | Defined | 2021-08-02 | |
| 2021-03-31 | $556,212,647 | 2,977,265 | Shares | Defined | 2021-04-30 | |
| 2020-12-31 | $525,934,742 | 3,114,989 | Shares | Defined | 2021-02-05 | |
| 2020-09-30 | $498,272,917 | 3,366,254 | Shares | Defined | 2020-10-30 | |
| 2020-06-30 | $585,524,492 | 3,566,357 | Shares | Defined | 2020-07-27 | |
| 2020-03-31 | $511,052,664 | 3,684,059 | Shares | Defined | 2020-04-27 | |
| No filing history on record for this holder in this stock. | ||||||